S&P 500 7,628.29 â–ŧ 57.85 (-0.75%) DOW 52,759.94 â–ŧ 425.96 (-0.80%) NASDAQ 26,096.35 â–ŧ 274.54 (-1.04%) US Markets Closed â€ĸ 07:31 PM ET

DERM

Journey Medical Corporation

Price Chart

No historical data available

Latest Quote

$7.47

-0.06 (-0.80%)
Current Price
Previous Close $7.53
Open $7.56
Day High $7.56
Day Low $7.38
Volume 122,960
Fetched: 2026-08-30T00:24:51
Stock Information
Shares Outstanding 22.22M
Total Debt $25.54M
Cash Equivalents $25.64M
Revenue $68.18M
Net Income $-6.10M
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
Market Cap $210.84M
EPS (TTM) $-0.22
Exchange NCM
🌐 Visit Website
Recent Price History
No history data available. Data will be fetched automatically.
About Journey Medical Corporation

Journey Medical Corporation, a commercial-stage pharmaceutical company that focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company's marketed products include Qbrexza, a medicated cloth towelette for the treatment of primary axillary hyperhidrosis; Accutane, an oral isotretinoin drug to treat severe recalcitrant nodular acne; and Amzeeq, a topical formulation of minocycline for the treatment of inflammatory lesions of non-nodular moderate to severe acne vulgaris. It also provides Zilxi, a topical minocycline treatment for inflammatory lesions of rosacea; Emrosi for the treatment of inflammatory lesions of rosacea; Exelderm cream and solution for the treatment of fungal skin infections; and Targadox, an oral doxycycline drug for adjunctive therapy for severe acne, as well as Luxamend, a water-based emulsion formulated to provide a moist healing environment for superficial wounds; minor cuts or scrapes; dermal ulcers; donor sites; first- and second-degree burns, including sunburns; and radiation dermatitis. The company was formerly known as Coronado Dermatology, Inc. Journey Medical Corporation was incorporated in 2014 and is headquartered in Scottsdale, Arizona.

📰 Latest News
No news articles available at the moment. Check back later for updates on DERM.
Period:
Loading...
Income Statement (Annual)
Metric 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Revenue
Reconciled Cost Of Revenue $20,836,000 $20,788,000 $22,805,000 $30,775,000
Cost Of Revenue $20,924,000 $20,879,000 $22,893,000 $30,775,000
Total Revenue $61,858,000 $56,134,000 $79,181,000 $73,669,000
Operating Revenue $61,239,000 $55,134,000 $59,662,000 $70,995,000
Expenses
Interest Expense $3,698,000 $2,700,000 $1,698,000 $2,019,000
Total Expenses $70,030,000 $74,364,000 $78,111,000 $101,186,000
Other Income Expense $-90,000 $5,562,000 $-3,326,000 $-89,000
Net Non Operating Interest Income Expense $-3,109,000 $-1,943,000 $-1,376,000 $-1,959,000
Interest Expense Non Operating $3,698,000 $2,700,000 $1,698,000 $2,019,000
Operating Expense $49,106,000 $53,485,000 $55,218,000 $70,411,000
Income & Earnings
Net Income From Continuing Operation Net Minority Interest $-11,431,000 $-14,672,000 $-3,853,000 $-29,628,000
Net Interest Income $-3,109,000 $-1,943,000 $-1,376,000 $-1,959,000
Interest Income $589,000 $757,000 $322,000 $60,000
Normalized Income $-11,359,900 $-19,065,980 $-1,225,460 $-29,539,000
Net Income From Continuing And Discontinued Operation $-11,431,000 $-14,672,000 $-3,853,000 $-29,628,000
Total Operating Income As Reported $-8,172,000 $-13,677,000 $-2,073,000 $-27,517,000
Net Income Common Stockholders $-11,431,000 $-14,672,000 $-3,853,000 $-29,628,000
Net Income $-11,431,000 $-14,672,000 $-3,853,000 $-29,628,000
Net Income Including Noncontrolling Interests $-11,431,000 $-14,672,000 $-3,853,000 $-29,628,000
Net Income Continuous Operations $-11,431,000 $-14,672,000 $-3,853,000 $-29,628,000
Pretax Income $-11,371,000 $-14,611,000 $-3,632,000 $-29,565,000
Special Income Charges $0 $5,678,000 $-3,143,000 $0
Interest Income Non Operating $589,000 $757,000 $322,000 $60,000
Operating Income $-8,172,000 $-18,230,000 $1,070,000 $-27,517,000
Depreciation Amortization Depletion Income Statement $4,258,000 $3,424,000 $3,767,000 -
Depreciation And Amortization In Income Statement $4,258,000 $3,424,000 $3,767,000 -
Amortization Of Intangibles Income Statement $4,258,000 $3,424,000 $3,767,000 -
Gross Profit $40,934,000 $35,255,000 $56,288,000 $42,894,000
Per Share
Diluted EPS $-0.47 $-0.72 $-0.21 $-1.69
Basic EPS $-0.47 $-0.72 $-0.21 $-1.69
Other
Tax Effect Of Unusual Items $-18,900 $1,168,020 $-698,460 $0
Tax Rate For Calcs $0 $0 $0 $0
Normalized EBITDA (Bullshit earnings) $-3,237,000 $-13,958,000 $5,247,000 $-23,092,000
Total Unusual Items $-90,000 $5,562,000 $-3,326,000 $-89,000
Total Unusual Items Excluding Goodwill $-90,000 $5,562,000 $-3,326,000 $-89,000
Reconciled Depreciation $4,346,000 $3,515,000 $3,855,000 $4,365,000
EBITDA (Bullshit earnings) $-3,327,000 $-8,396,000 $1,921,000 $-23,181,000
EBIT $-7,673,000 $-11,911,000 $-1,934,000 $-27,546,000
Diluted Average Shares $24,497,973 $20,431,400 $18,232,422 $17,531,274
Basic Average Shares $24,497,973 $20,431,400 $18,232,422 $17,531,274
Diluted NI Availto Com Stockholders $-11,431,000 $-14,672,000 $-3,853,000 $-29,628,000
Tax Provision $60,000 $61,000 $221,000 $63,000
Gain On Sale Of Security $-90,000 $-116,000 $-183,000 $-89,000
Amortization $4,258,000 $3,424,000 $3,767,000 -
Research And Development $480,000 $9,857,000 $7,541,000 $10,943,000
Selling General And Administration $44,368,000 $40,204,000 $43,910,000 $59,468,000
Other Special Charges - $-5,678,000 - -
Impairment Of Capital Assets - $0 $3,143,000 $0
Fetched: 2026-08-30
Balance Sheet (Annual)
Metric 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Assets
Net Tangible Assets $4,247,000 $-11,794,000 $63,000 $-10,215,000
Total Assets $94,589,000 $80,241,000 $76,849,000 $105,160,000
Total Non Current Assets $27,716,000 $32,062,000 $20,394,000 $27,481,000
Goodwill And Other Intangible Assets $27,605,000 $31,863,000 $20,287,000 $27,197,000
Other Intangible Assets $27,605,000 $31,863,000 $20,287,000 $27,197,000
Current Assets $66,873,000 $48,179,000 $56,455,000 $77,679,000
Other Current Assets $3,376,000 $3,212,000 $3,588,000 $3,309,000
Inventory $9,624,000 $14,431,000 $10,206,000 $14,159,000
Receivables $29,783,000 $10,231,000 $15,222,000 $28,208,000
Accounts Receivable $29,783,000 $10,231,000 $15,222,000 $28,208,000
Allowance For Doubtful Accounts Receivable $-200,000 $-600,000 $-500,000 $-400,000
Gross Accounts Receivable $29,983,000 $10,831,000 $15,722,000 $28,608,000
Cash Cash Equivalents And Short Term Investments $24,090,000 $20,305,000 $27,439,000 $32,003,000
Cash And Cash Equivalents $24,090,000 $20,305,000 $27,439,000 $32,003,000
Other Non Current Assets - - $6,000 $95,000
Non Current Deferred Assets - - - -
Non Current Deferred Taxes Assets - - - -
Prepaid Assets - - - -
Debt
Net Debt $1,187,000 $4,574,000 - -
Total Debt $25,396,000 $25,080,000 $14,730,000 $22,965,000
Long Term Debt And Capital Lease Obligation $25,295,000 $24,997,000 $14,631,000 $19,934,000
Long Term Debt $25,277,000 $24,879,000 $14,622,000 $19,826,000
Current Debt And Capital Lease Obligation $101,000 $83,000 $99,000 $3,031,000
Current Debt - - - $2,948,000
Liabilities
Total Liabilities Net Minority Interest $62,737,000 $60,172,000 $56,499,000 $88,178,000
Total Non Current Liabilities Net Minority Interest $25,295,000 $24,997,000 $14,631,000 $21,346,000
Current Liabilities $37,442,000 $35,175,000 $41,868,000 $66,832,000
Payables And Accrued Expenses $29,575,000 $27,965,000 $30,958,000 $49,706,000
Interest Payable $398,000 $404,000 $22,000 $160,000
Payables $11,181,000 $18,012,000 $20,412,000 $39,645,000
Other Payable $1,805,000 $1,374,000 $2,015,000 $2,627,000
Total Tax Payable $70,000 $60,000 $53,000 $35,000
Income Tax Payable $70,000 $60,000 $53,000 $35,000
Accounts Payable $8,851,000 $16,050,000 $18,149,000 $36,983,000
Other Current Liabilities - $625,000 $3,360,000 $2,829,000
Current Deferred Liabilities - - $0 $4,991,000
Other Non Current Liabilities - - - $1,412,000
Tradeand Other Payables Non Current - - - -
Equity
Common Stock Equity $31,852,000 $20,069,000 $20,350,000 $16,982,000
Total Equity Gross Minority Interest $31,852,000 $20,069,000 $20,350,000 $16,982,000
Stockholders Equity $31,852,000 $20,069,000 $20,350,000 $16,982,000
Retained Earnings $-98,458,000 $-87,027,000 $-72,355,000 $-68,502,000
Other
Ordinary Shares Number $27,144,655 $22,153,610 $19,323,952 $17,765,700
Share Issued $27,144,655 $22,153,610 $19,323,952 $17,765,700
Tangible Book Value $4,247,000 $-11,794,000 $63,000 $-10,215,000
Invested Capital $57,129,000 $44,948,000 $34,972,000 $39,756,000
Working Capital $29,431,000 $13,004,000 $14,587,000 $10,847,000
Capital Lease Obligations $119,000 $201,000 $108,000 $191,000
Total Capitalization $57,129,000 $44,948,000 $34,972,000 $36,808,000
Additional Paid In Capital $130,307,000 $107,094,000 $92,703,000 $85,482,000
Capital Stock $3,000 $2,000 $2,000 $2,000
Common Stock $3,000 $2,000 $2,000 $2,000
Long Term Capital Lease Obligation $18,000 $118,000 $9,000 $108,000
Current Capital Lease Obligation $101,000 $83,000 $99,000 $83,000
Pensionand Other Post Retirement Benefit Plans Current $5,589,000 $3,378,000 $3,374,000 $2,586,000
Current Provisions $2,177,000 $3,124,000 $4,077,000 $3,689,000
Current Accrued Expenses $18,394,000 $9,953,000 $10,546,000 $10,061,000
Dueto Related Parties Current $455,000 $528,000 $195,000 $413,000
Net PPE $111,000 $199,000 $101,000 $189,000
Gross PPE $111,000 $199,000 $101,000 $189,000
Other Properties $111,000 $199,000 $101,000 $189,000
Inventories Adjustments Allowances $-996,000 $-513,000 $-305,000 $-429,000
Finished Goods $7,389,000 $11,381,000 $4,987,000 $7,739,000
Work In Process $174,000 $367,000 $884,000 $395,000
Raw Materials $3,057,000 $3,196,000 $4,640,000 $6,454,000
Line Of Credit - - $0 $2,948,000
Fetched: 2026-08-30
Cash Flow Statement (Annual)
Metric 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Free Cash Flow
Free Cash Flow $-12,441,000 $-24,127,000 $240,000 $-33,534,000
Operating Activities
Operating Cash Flow $-12,441,000 $-9,127,000 $5,240,000 $-13,534,000
Cash Flow From Continuing Operating Activities $-12,441,000 $-9,127,000 $5,240,000 $-13,534,000
Operating Gains Losses - $-1,125,000 - -
Investing Activities
Investing Cash Flow $0 $-15,000,000 $-5,000,000 $-20,000,000
Cash Flow From Continuing Investing Activities $0 $-15,000,000 $-5,000,000 $-20,000,000
Capital Expenditure - $-15,000,000 $-5,000,000 $-20,000,000
Net Other Investing Changes - - - $-20,000,000
Financing Activities
Financing Cash Flow $16,226,000 $16,993,000 $-4,804,000 $16,456,000
Cash Flow From Continuing Financing Activities $16,226,000 $16,993,000 $-4,804,000 $16,456,000
Net Other Financing Charges $-75,000 $-50,000 $-471,000 $-585,000
Issuance Of Capital Stock - - $4,494,000 $0
Net Common Stock Issuance - - $4,494,000 $0
Common Stock Issuance - - $4,494,000 $0
Net Preferred Stock Issuance - - - $0
Preferred Stock Issuance - - - $0
Other
Repayment Of Debt $-625,000 $-1,250,000 $-51,948,000 $-7,864,000
Issuance Of Debt $16,359,000 $17,877,000 $47,494,000 $24,763,000
Interest Paid Supplemental Data $3,238,000 $2,011,000 $1,127,000 $993,000
Income Tax Paid Supplemental Data $50,000 $125,000 $181,000 $168,000
End Cash Position $24,090,000 $20,305,000 $27,439,000 $32,003,000
Beginning Cash Position $20,305,000 $27,439,000 $32,003,000 $49,081,000
Changes In Cash $3,785,000 $-7,134,000 $-4,564,000 $-17,078,000
Proceeds From Stock Option Exercised $567,000 $416,000 $121,000 $142,000
Net Issuance Payments Of Debt $15,734,000 $16,627,000 $-4,454,000 $16,899,000
Net Long Term Debt Issuance $15,734,000 $16,627,000 $-1,506,000 $14,763,000
Long Term Debt Payments $-625,000 $-1,250,000 $-21,000,000 $-5,000,000
Long Term Debt Issuance $16,359,000 $17,877,000 $19,494,000 $19,763,000
Net Intangibles Purchase And Sale $0 $-15,000,000 $-5,000,000 $-20,000,000
Purchase Of Intangibles $0 $-15,000,000 $-5,000,000 $-20,000,000
Change In Working Capital $-11,899,000 $-3,766,000 $-1,655,000 $6,187,000
Change In Other Current Liabilities $-82,000 $-96,000 $-83,000 $-95,000
Change In Other Current Assets $0 $6,000 $0 $55,000
Change In Payables And Accrued Expense $2,881,000 $-4,302,000 $-17,797,000 $10,734,000
Change In Accrued Expense $10,070,000 $-2,210,000 $606,000 $-3,636,000
Change In Interest Payable $-6,000 $382,000 $-138,000 $160,000
Change In Payable $-7,189,000 $-2,092,000 $-18,403,000 $14,370,000
Change In Account Payable $-7,199,000 $-2,099,000 $-18,421,000 $14,343,000
Change In Tax Payable $10,000 $7,000 $18,000 $27,000
Change In Income Tax Payable $10,000 $7,000 $18,000 $27,000
Change In Prepaid Assets $-164,000 $376,000 $-279,000 $-871,000
Change In Inventory $4,807,000 $-4,225,000 $3,953,000 $1,744,000
Change In Receivables $-19,341,000 $4,475,000 $12,551,000 $-5,380,000
Changes In Account Receivables $-19,341,000 $4,475,000 $12,551,000 $-5,380,000
Other Non Cash Items $466,000 $307,000 $709,000 $833,000
Stock Based Compensation $6,288,000 $6,098,000 $2,606,000 $4,425,000
Asset Impairment Charge $-211,000 $516,000 $3,578,000 $284,000
Depreciation Amortization Depletion $4,346,000 $3,515,000 $3,855,000 $4,365,000
Depreciation And Amortization $4,346,000 $3,515,000 $3,855,000 $4,365,000
Amortization Cash Flow $4,258,000 $3,424,000 $3,767,000 $4,277,000
Amortization Of Intangibles $4,258,000 $3,424,000 $3,767,000 $4,277,000
Depreciation $88,000 $91,000 $88,000 $88,000
Net Income From Continuing Operations $-11,431,000 $-14,672,000 $-3,853,000 $-29,628,000
Net Short Term Debt Issuance - $0 $-2,948,000 $2,136,000
Short Term Debt Payments - $0 $-30,948,000 $-2,864,000
Short Term Debt Issuance - $0 $28,000,000 $5,000,000
Deferred Tax - - - $0
Deferred Income Tax - - - $0
Gain Loss On Investment Securities - - - -
Fetched: 2026-08-30